Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Association of Acute Carotid Stenting with Functional Outcome Mediated by Successful Reperfusion in Tandem Lesions: Mediation Analysis of a Multicenter Registry

Author:Rodriguez-Calienes, Aaron   Galecio-Castillo, Milagros   Hassan, Ameer   Jumaa, Mouhammad   Divani, Afshin   Ribo, Marc   Abraham, Michael   Petersen, Nils   Fifi, Johanna   Guerrero, Waldo   Malik, Amer   Siegler, James   Nguyen, Thanh   Sheth, Sunil   Yoo, Albert   Linares, Guillermo   Janjua, Nazli   Quispe-Orozco, Darko   Lu, Yujing   Vivanco-Suarez, Juan   Dibas, Mahmoud   Mokin, Maxim   Yavagal, Dileep   Ortega-Gutierrez, Santiago   

Session Name:P2: Cerebrovascular Disease and Interventional Neurology: Epidemiology and Community Stroke Care  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P2.006  

Author Institution:University of Iowa Hospitals and Clinics, Iowa City, IA  University of Iowa Hopitals and Clinics, Iowa City, IA  Valley Baptist Medical Center, Harlingen, TX  ProMedica Stroke Network, Toledo, OH  University of New Mexico, Albuquerque, NM  Hospital vall d'Hebron, Barcelona, Spain  The University of Kansas Health System, Kansas City, KS  Yale University, New Haven, CT  Mount Sinai Hospital, New York, NY  University of South Florida, Tampa, FL  University of Miami Miller School of Medicine, Miami, FL  Cooper University Hospital, Camden, NJ  Boston Medical Center, Boston, MA  University of Texas At Houston, Houston, TX  Texas Stroke Institute, Dallas, TX  Saint Louis University, St. Louis, MT  Pomona Valley Hospital Medical Center, Montclair, CA  

Long-term Efficacy of the Sphingosine 1-Phosphate Receptor Modulator Ozanimod by Age Category in Patients with Relapsing Multiple Sclerosis: Final Results from Two Phase 3 Trials and an Open-label Extension Trial

Author:Steinman, Lawrence   Selmaj, Krzysztof   Comi, Giancarlo   Bar-Or, Amit   Arnold, Douglas   Hartung, Hans-Peter   Montalban, Xavier   Havrdova, Eva   Sheffield, James   Cheng, Chun-Yen   Reardon, Jennifer   Riolo, Jon   Deboer, Erik   Kappos, Ludwig   Cohen, Jeffrey   Cree, Bruce   

Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2  

Topic:Multiple Sclerosis  

Program Number:P2.007  

Author Institution:Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, Stanford, CA  Center for Neurology, Lódz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, Lodz, Poland  Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, PA  NeuroRx Research and Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada, Montreal, QC, Canada  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Australia  Department of Neurology, Medical University of Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic, Prague, Czech Republic  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA  

Multiple Sclerosis Treatment and Holistic Patient Care Consensus by the Spanish Society of Neurology

Author:Meca Lallana, José E.   Martínez Yélamos, Sergio   Eichau Madueno, Sara   Llaneza, Miguel Ángel   Martín Martínez, Jesús   Peña-Martínez, Joaquín   Meca-Lallana, Virginia   Alonso Torres, Ana María   Moral Torres, Ester   Río, Jordi   Calles, Carmen   Ares Luque, Adrián   Ramio Torrenta, Lluis   Marzo Sola, María Eugenia   Prieto, José María   Martínez Ginés, María Luisa   Arroyo Gonzalez, Rafael   Otano Martínez, María Ángeles   Brieva Ruiz, Luis   Gómez Guitiérrez, Montserrat   Rodríguez-Antigüedad Zarranz, Alfredo   Galán Sánchez Seco, Victoria   Costa-Frossard, Lucienne   Hernández Pérez, Miguel Ángel   Landete-Pascual, Lamberto   Gonzalez Platas, Montserrat   Oreja-Guevara, Celia   

Session Name:P3: Multiple Sclerosis: Therapeutics and Symptom Management  

Topic:Multiple Sclerosis  

Program Number:P3.013  

Author Institution:Clinic Neuroimmunology Unit and Multiple Sclerosis CSUR, Department of Neurology. Hospital Clínico Universitario Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain  Multiple Sclerosis Unit “EMxarxa”. Department of Neurology. H.U. de Bellvitge, Barcelona, Spain  Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain  Department of Neurology, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain  Department of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain  Department of Neurology, Hospital Universitario San Agustín, Avilés, Spain  Department of Neurology, Hospital Universitario La Princesa, Madrid, Spain  Multiple Sclerosis Unit, Department of Neurology, Hospital Regional Universitario de Málaga, Málaga, Spain  Department of Neurology, Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain  Department of Neurology, CemCat-Vall d’Hebrón, Barcelona, Spain  Department of Neurology, Hospital Universitari Son Espases, Palma De Mallorca, Spain  Department of Neurology, Complejo Asistencial Universitario de León, León, Spain  Multiple Sclerosis and Neuroimmunology Unit, Hospital Universitario Dr. Josep Trueta and Hospital Santa Caterina, Girona, Spain  Department of Neurology, Hospital San Pedro, Logroño, Spain  Department of Neurology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain  Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid, Spain  Department of Neurology, Hospital Universitario Quiron Salud Madrid, Madrid, Spain  Department of Neurology, Complejo Hospitalario de Navarra, Navarra, Spain  Universitat de Lleida, Hospital Universitari Arnau de Vilanova, Lerida, Spain  Department of Neurology, Hospital Universitario de Cáceres, Cáceres, Spain  Department of Neurology, Hospital Universitario Cruces, Barakaldo, Spain  Department of Neurology, Hospital Universitario de Toledo, Toledo, Spain  Multiple Sclerosis Unit, Ramón y Cajal University Hospital, Madrid, Spain  Department of Neurology, Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain  Department of Neurology, Hospital Universitario Dr Peset, Valencia, Spain  Department of Neurology, Hospital Universitario de Canarias, La Laguna, Spain  Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain  

Relapse-associated Worsening and Progression-independent Relapse Activity in Ozanimod-treated Participants with Relapsing Multiple Sclerosis from the RADIANCE and DAYBREAK Trials

Author:Filippi, Massimo   Riolo, Jon   Cohen, Jeffrey   Hartung, Hans-Peter   Montalban, Xavier   Meuth, Sven   Freeman, Leorah   Chitnis, Tanuja   Granziera, Cristina   Deboer, Erik   Cheng, Chun-Yen   Reardon, Jennifer   Pachai, Chahin   Sheffield, James   Cree, Bruce   Kappos, Ludwig   

Session Name:P6: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 2  

Topic:Multiple Sclerosis  

Program Number:P6.014  

Author Institution:Neuroimaging Research Unit, Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy, Milan, Italy  Bristol Myers Squibb, Princeton, New Jersey, USA, Princeton, NJ  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, USA, Cleveland, OH  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Sydney, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Duesseldorf, Germany  Dell Medical School, The University of Texas at Austin, Austin, Texas, USA, Austin, TX  Brigham and Women’s Hospital, and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA, Boston, MA  Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland  Department of Neurology, University Hospital Basel, Switzerland  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  Bristol Myers Squibb, Princeton, New Jersey, USA, New York, NY  Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA , San Francisco, CA